K-RAS GENE MUTATION

K-RAS GENE MUTATION was reported 106 times

These drug classes are most commonly taken by patients reporting K-RAS GENE MUTATION:

# Drug Count
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 44
1 Platinum-based Drug [EPC] 42
2 Aromatase Inhibitor [EPC] 27
3 Nucleoside Metabolic Inhibitor [EPC] 20
4 Kinase Inhibitor [EPC] 16
5 Aldosterone Antagonist [EPC] 14
6 Epidermal Growth Factor Receptor Antagonist [EPC] 13
7 Folate Analog Metabolic Inhibitor [EPC] 13
8 Microtubule Inhibitor [EPC] 13
9 Loop Diuretic [EPC] 12
10 Programmed Death Receptor-1 Blocking Antibody [EPC] 9
11 Alkylating Drug [EPC] 4
12 Antimetabolite [EPC] 4
13 Corticosteroid [EPC] 3
14 Nucleoside Analog Antiviral [EPC] 3
15 Dihydropyridine Calcium Channel Blocker [EPC] 2
16 Erythropoiesis-stimulating Agent [EPC] 2
17 HER2/neu Receptor Antagonist [EPC] 2
18 Opioid Agonist [EPC] 2
19 Programmed Death Ligand-1 Blocker [EPC] 2
20 Proteasome Inhibitor [EPC] 2
21 Aluminum Complex [EPC] 1
22 Angiotensin 2 Receptor Blocker [EPC] 1
23 Anti-epileptic Agent [EPC] 1
24 Asparagine-specific Enzyme [EPC] 1
25 BCL-2 Inhibitor [EPC] 1
26 Benzodiazepine [EPC] 1
27 CD20-directed Cytolytic Antibody [EPC] 1
28 CD22-directed Immunoconjugate [EPC] 1
29 CD38-directed Cytolytic Antibody [EPC] 1
30 Calcineurin Inhibitor Immunosuppressant [EPC] 1
31 Calcium Channel Blocker [EPC] 1
32 Complement Inhibitor [EPC] 1
33 Estrogen Receptor Antagonist [EPC] 1
34 GLP-1 Receptor Agonist [EPC] 1
35 HMG-CoA Reductase Inhibitor [EPC] 1
36 Interleukin-17A Antagonist [EPC] 1
37 Interleukin-23 Antagonist [EPC] 1
38 Janus Kinase Inhibitor [EPC] 1
39 Leukocyte Growth Factor [EPC] 1
40 Osmotic Laxative [EPC] 1
41 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
42 Potassium Salt [EPC] 1
43 Purine Antimetabolite [EPC] 1
44 RANK Ligand Inhibitor [EPC] 1
45 Retinoid [EPC] 1
46 Serotonin-3 Receptor Antagonist [EPC] 1
47 Thalidomide Analog [EPC] 1
48 Topoisomerase Inhibitor [EPC] 1
49 Vitamin B12 [EPC] 1
50 Vitamin C [EPC] 1
51 Vitamin D [EPC] 1
52 alpha-Adrenergic Blocker [EPC] 1
53 beta-Adrenergic Blocker [EPC] 1
54 mTOR Inhibitor Immunosuppressant [EPC] 1